Mesothelioma Issues

8/04 We are being contacted by group after group dealing with mesothelioma. But most of them seem to handle legal issues as opposed to health.

Mesothelioma Markers and Monitors

'SMR is a sensitive marker of disease when tumour bulk is small'

Mesothelioma is a highly aggressive tumour for which there are no reliable serum tumour markers. Bruce Robinson and colleagues assayed serum concentrations of soluble mesothelin-related proteins (SMR) using a double determinant (sandwich) ELISA.

They found that more patients with mesothelioma had raised concentrations of SMR than did those with other cancers or other inflammatory lung or pleural diseases. SMR concentrations were also correlated with the size of the tumour and increased during tumour progression.

The authors conclude that determination of SMR in serum could be a useful marker for diagnosis of mesothelioma and to monitor disease progression.

Lancet Volume 362, Number 9396, November 15, 2003


Asbestos News

LINK Info site reviewing hazards of asbestos exposure & various forms of associated cancers it causes

Gene Test Distinguishes Lung Adenocarcinoma from Mesothelioma

Clin Cancer Res, 9/06

Single-Dose RTx & Mesothelioma: Ineffective

Br J Cancer, 6/04

Lung Ca & Mesothelioma Screening w/Low-dose Spiral CT

Abstract # 7048 ASCO, 2004

Clove Extract Neutralizes Asbestos Fiber

J Chemical Communications, 10/01

Primary Peritoneal Mesothelioma: Treatment Issues

Abstract # 4132 ASCO, 2004

Organizations for Mesothelioma

LINKS to groups dealing with Mesothelioma

New Bd Chair for Mesothelioma Applied Res Fdntn
Law Firms
Apigenin, Apoptosis & Pleural Mesothelioma Cells

Abstract #B127 Frontiers in Cancer Prevention Res, 2003

Cancer Mortality in a Cohort of Asbestos Textile Workers

British J Cancer, 2/05

Surviving Mesothelioma w/Alt Therapies

Story from cancermonthly.com, January 2005 Paul Kraus

Book: Surviving Mesothelioma and Other Cancers

Author, Paul Kraus 11/05

Asbestos News

LINK to newsletter on "information about Mesothelioma & Asbestos Exposure

Chemotherapy Doesn't Help in Malignant Mesolthelioma

Am Society of Clinical Oncology, Annual Meeting, June 2007


Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.